Finance

Beta
Lists
OSE:EPA
Ose Immunotherapeutics SA
3,49 €
-2,57%
(-0,092) 1D
19 հնս, 17:39:36 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for OSE...
Open
3,58 €
High
3,65 €
Low
3,49 €
Mkt. cap
77,66 մլն
Avg. vol.
323,76 հզր
Volume
73,68 հզր
52-wk high
7,70 €
52-wk low
2,87 €
EPS
-1,69 €
Shares outstanding
22,68 մլն
No. of employees
64
Open
3,58 €
High
3,65 €
Low
3,49 €
Mkt. cap
77,66 մլն
Avg. vol.
323,76 հզր
Volume
73,68 հզր
52-wk high
7,70 €
52-wk low
2,87 €
EPS
-1,69 €
Shares outstanding
22,68 մլն
No. of employees
64
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to OSE in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for OSE in the last 3 months.
Highest
Current 3,49 €
8,20 € (+134,82%)
Average
8,20 € (+134,82%)
Lowest
8,20 € (+134,82%)
News stories
From sources across the web
About Ose Immunotherapeutics SA
CEO-
Employees64
Founded17 նոյ, 2004 թ.
Headquarters-
Sector-
Websiteose-immuno.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
2024 թ. հնս
2024 թ. սեպ
2024 թ. դեկ
Revenue
41,29 մլն
431,00 հզր
431,00 հզր
Cost of goods sold
-
-
-
Cost of revenue
-
-
-
Research and development expenses
6,94 մլն
8,28 մլն
8,28 մլն
Total research and development expenses
-
-
-
Selling, general, and admin expenses
2,05 մլն
1,08 մլն
1,08 մլն
Operating expense
9,63 մլն
10,22 մլն
10,22 մլն
Total operating expenses
9,63 մլն
10,22 մլն
10,22 մլն
Operating income
31,66 մլն
-9,79 մլն
-9,79 մլն
Other non operating income
-596,00 հզր
-611,00 հզր
-611,00 հզր
EBT including unusual items
30,36 մլն
-10,44 մլն
-10,44 մլն
EBT excluding unusual items
30,33 մլն
-10,53 մլն
-10,53 մլն
Income tax expense
1,77 մլն
-576,50 հզր
-576,50 հզր
Effective tax rate
5,83%
5,52%
5,52%
Other operating expenses
94,50 հզր
41,00 հզր
41,00 հզր
Net income
28,59 մլն
-9,86 մլն
-9,86 մլն
Net profit margin
69,24%
-2 288,86%
-2 288,86%
Earnings per share
-
-
-
Interest and investment income
162,50 հզր
571,00 հզր
571,00 հզր
Interest expense
-878,50 հզր
-707,50 հզր
-707,50 հզր
Net interest expenses
-716,00 հզր
-136,50 հզր
-136,50 հզր
Depreciation and amortization charges
-
-
-
EBITDA
31,72 մլն
-9,74 մլն
-9,74 մլն
Gain or loss from assets sale
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer